Used in pharmaceutical research as an intermediate for synthesizing bioactive compounds targeting central nervous system disorders. Shows potential in the development of agents with sedative and anxiolytic properties due to its structural affinity for GABA receptors. Investigated for use in treatments of epilepsy and insomnia in preclinical studies. Also employed in the preparation of quinazoline-based derivatives with antimicrobial and anticancer activity. Its scaffold is valued in medicinal chemistry for optimizing drug candidates with enhanced blood-brain barrier penetration.